Company overview
deepmatter provides DigitalGlassware, a platform for capturing, structuring, and analyzing chemical reaction data to enhance reproducibility in pharmaceutical R&D. It integrates AI for predicting molecules, optimizing reactions, and accelerating drug discovery through partnerships like AstraZeneca and acquisitions such as ChemIntelligence. The technology supports automated synthesis, cloud-based data sharing, and AI-driven insights for preclinical development.
ChemAI is listed in the NovaPharmaNews Supplier Hub as a Software & Digital Lab partner serving United States & Americas. Core focus areas include chemistry ai, digitalglassware, reaction data platform, drug discovery software, chemical reproducibility.
Industry categories: Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with ChemAI include Software — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.deepmatter.io
- Categories
- Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- chemistry ai, digitalglassware, reaction data platform, drug discovery software, chemical reproducibility
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What is deepmatter's core technology for pharma R&D?
- DigitalGlassware captures real-time chemical reaction data including temperature, pressure, and catalysts, structuring it for AI analysis, reproducibility, and automated synthesis optimization.
- What partnerships demonstrate deepmatter's capabilities?
- deepmatter partners with AstraZeneca to improve compound synthesis productivity and reproducibility, and trialed its platform with Aurigene for custom drug discovery acceleration.
- How does deepmatter support regulatory compliance and data security?
- The platform operates in a secure end-to-end cloud environment, enabling structured data capture compliant with reproducibility standards for clinical trials and preclinical development.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
